Breaking Finance News

Transenterix Inc (NASDAQ:TRXC) has been downgraded to Hold in a report by Zacks Investment Research today.

Zacks Investment Research has downgraded Transenterix Inc (NASDAQ:TRXC) to Hold in a statement released on Wednesday October 12, 2016.

On 10/11/2016, B. Riley released a statement on Transenterix Inc (NASDAQ:TRXC) upped the target price from $0.00 to $3.00 that suggested an upside of 0.53%.

Having a price of $2.09, Transenterix Inc (NASDAQ:TRXC) traded 3.16% higher on the day. With the last close up -0.73% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Transenterix Inc has recorded a 50-day average of $1.55 and a two hundred day average of $1.97. Volume of trade was up over the average, with 1,224,380 shares of TRXC changing hands over the typical 768,586

Performance Chart

Transenterix Inc (NASDAQ:TRXC)

With a total market value of $0, Transenterix Inc has with a one year low of $1.03 and a one year high of $6.10 .

A total of 7 analysts have released a research note on Transenterix Inc. Three analysts rating the company a strong buy, four analysts rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $4.04.

More About Transenterix Inc (NASDAQ:TRXC)

TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.